Portal Hypertension

Top Story

AASLD Foundation presents grants to young hepatologists for research, careers

AASLD Foundation presents grants to young hepatologists for research, careers
July 18, 2019
Meeting News

Emricasan reduces portal pressure in cirrhosis despite missing endpoint

April 13, 2019
VIENNA — Emricasan missed its primary endpoint of hepatic venous pressure gradient reduction in all patients with nonalcoholic steatohepatitis-related compensated…
In the Journals

Extrahepatic conditions increase complication risk in portal hypertension

April 1, 2019
Patients with idiopathic noncirrhotic portal hypertension had a high risk for major surgical and portal hypertension-related complications if they also had extrahepatic…
In the Journals

Norfloxacin ineffective for cirrhosis survival, but beneficial in ascites

September 6, 2018
Results of a randomized control trial of patients with advanced cirrhosis without recent fluoroquinolone therapy showed that norfloxacin did not reduce 6-month mortality…
More Headlines »
CME

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »
GI Bookshelf

Question 24: A 65-Year-Old Male On Plavix Following A Recent Mi And Coronary Stenting Was Seen In The Er With Fever, Pain, Jaundice, And A Wbc Of 18,000. Us Showed A Dilated Bile Duct Of 15 Mm And A Gallbladder Full Of Stones. Mrcp Revealed A 15-Mm Stone In The Distal Cbd. What Would You Do?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Video
Meeting News

VIDEO: Liver disease topics discussed at DDW include HCV, NAFLD, statins

May 12, 2017
More »
Healio Jobs